Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 38320179

Vemurafenib and Obinutuzumab as Frontline Therapy for Hairy Cell Leukemia.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
NEJM Evid
Publication date
2023 Oct
First author
Park JH

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    NEJM Evid. 2023 Oct;2(10):EVIDe2300173. doi: 10.1056/EVIDe2300173.
    note
    Source null
    related pmid
    38320184
    relationship
    Comment in

Authors and identifiers

  1. name
    Park JH
    type
    Author
  2. name
    Devlin S
    type
    Author
  3. name
    Durham BH
    type
    Author
  4. name
    Winer ES
    type
    Author
  5. name
    Huntington S
    type
    Author
  6. name
    von Keudell G
    type
    Author
  7. name
    Vemuri S
    type
    Author
  8. name
    Shukla M
    type
    Author
  9. name
    Falco V
    type
    Author
  10. name
    Cuello B
    type
    Author
  11. name
    Gore S
    type
    Author
  12. name
    Stone R
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Park JH
    type
    Author
  2. name
    Devlin S
    type
    Author
  3. name
    Durham BH
    type
    Author
  4. name
    Winer ES
    type
    Author
  5. name
    Huntington S
    type
    Author
  6. name
    von Keudell G
    type
    Author
  7. name
    Vemuri S
    type
    Author
  8. name
    Shukla M
    type
    Author
  9. name
    Falco V
    type
    Author
  10. name
    Cuello B
    type
    Author
  11. name
    Gore S
    type
    Author
  12. name
    Stone R
    type
    Author
bibliography ids
  1. nci-bib-6b4869e0d6ee1ba74af07546
book metadata
content sha256
f08f3449bd9d9fbd695fe5d30543340c02bd98ffb6ed1064ead454028a0ead8d
document type
citation
dois
  1. 10.1056/EVIDoa2300074
electronic publication date
display
2023 Sep 21
precision
day
year
2023
evidence scope
bibliographic_metadata_only
id
pubmed:38320179
immutable id
pubmed:38320179@f08f3449bd9d9fbd695fe5d30543340c02bd98ffb6ed1064ead454028a0ead8d
journal
abbreviation
NEJM Evid
issn electronic
2766-5526
issn print
Source null
issue
10
name
NEJM evidence
nlm unique id
9918317485806676
pages
EVIDoa2300074
volume
2
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    NEJM Evid. 2023 Oct;2(10):EVIDe2300173. doi: 10.1056/EVIDe2300173.
    note
    Source null
    related pmid
    38320184
    relationship
    Comment in
outcomes validated
false
pmid
38320179
provenance
batch id
6d213eecf21b6b7867cb
provider
NCBI PubMed ESummary
record sha256
d03bcd3a811dfa5375502a8f940b550f5b54b901a9110662aa443e34a78b867b
response sha256
684f894a21d8f5f78a3bd0acd8ee4215ff94144487c53dab1056650ee8d6751d
retrieved at
2026-09-09T23:48:19.049083+00:00
publication date
display
2023 Oct
precision
month
year
2023
publication types
  1. Journal Article
  2. Research Support, Non-U.S. Gov't
  3. Research Support, N.I.H., Extramural
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/38320179/
title
Vemurafenib and Obinutuzumab as Frontline Therapy for Hairy Cell Leukemia.

Preserved source evidence · Not medical advice